Applied Therapeutics Stock (NASDAQ: APLT) stock price, news, charts, stock research, profile.
You can purchase shares of Applied Therapeutics (NASDAQ:APLT) through any online brokerage.
Other companies in Applied Therapeutics’s space includes: Cabaletta Bio (NASDAQ:CABA), Adverum Biotechnologies (NASDAQ:ADVM), OS Therapies (AMEX:OSTX), Century Therapeutics (NASDAQ:IPSC) and Lineage Cell Therapeutics (AMEX:LCTX).
Applied Therapeutics has a consensus price target of $5.46.
The stock price for Applied Therapeutics (NASDAQ: APLT) is $0.8764 last updated December 27, 2024 at 7:59 PM EST.
There are no upcoming dividends for Applied Therapeutics.
Applied Therapeutics’s Q4 earnings are confirmed for Wednesday, March 5, 2025.
There is no upcoming split for Applied Therapeutics.
Applied Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.